Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
about
Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczemaEffects of systemic immunosuppressive therapies for moderate-to-severe eczema in children and adultsPsychological and educational interventions for atopic eczema in childrenS2k guideline on diagnosis and treatment of atopic dermatitis — short versionAtopic dermatitis and skin allergies - update and outlookDevelopment of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic reviewMeasurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review.Silk garments plus standard care compared with standard care for treating eczema in children: A randomised, controlled, observer-blind, pragmatic trial (CLOTHES Trial).The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey area.Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).Validation of treatment escalation as a definition of atopic eczema flares.A pilot comparison study of four clinician-rated atopic dermatitis severity scales.Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review.A multi-centre, parallel group superiority trial of silk therapeutic clothing compared to standard care for the management of eczema in children (CLOTHES Trial): study protocol for a randomised controlled trial.Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients.A review of patient and carer participation and the use of qualitative research in the development of core outcome setsThe natural history of milk allergy in an observational cohort.The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference.Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians.Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research.How are eczema 'flares' defined? A systematic review and recommendation for future studies.New approaches to the prevention of childhood atopic dermatitis.Optimizing outcomes for paediatric atopic dermatitis.Update on skin allergy.Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review.Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.Measuring long-term disease control in patients with atopic dermatitis: A validation study of well-controlled weeks.Chinese herbal medicine for atopic eczema: an overview of clinical evidence.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
P2860
Q24185954-863441AF-739F-4D1F-8450-6F8001A68A66Q24188221-BBA50AE6-F5DE-46F8-A756-61FFAC88C8F5Q24201204-40FFDB0D-9273-4334-B744-F8169EABFBDAQ26744978-17F65F57-022A-4690-8909-335D1F436DF6Q26851924-C25B7E93-1236-40BD-A4F9-6A9921D8C1E4Q27332058-4589614E-AAAA-4CF8-B053-785858AAE221Q28078864-F0588A35-44C4-4D44-9111-9DB0250E4128Q30248379-26A77D1A-76F8-4EF8-BE04-B20D4A9AD828Q33554332-26AD6636-3ECF-4C5D-B43F-A06536731084Q33641173-81B230C6-6129-45F6-898A-34E11E17FE2FQ34388802-8D14B200-BB9C-48B2-BA69-05B9BA6C5BE9Q34982055-064CC4D0-3234-49DB-8A8E-C14AEB73B22AQ35515891-D744DB8D-DC20-4854-8B0C-B23D6CAFD577Q35609349-605A5D71-7193-48A9-B69D-36DBE73A96A9Q35618978-27772AFA-7322-48F3-B166-87FB59077144Q36020199-2234D5AB-3042-435F-B27B-3EB8B3B72CC4Q36056978-70EDF165-8570-4465-BD88-8CBA01059D4CQ36232707-0A986D10-3C3D-4A00-8813-CBF367FDDB7BQ36310440-16D7E92E-D8A9-40F7-AE72-49D5EAEC8778Q36951010-374F58F7-8CC0-483D-B1D0-B6BA9A62C9B9Q37420419-84EF610D-1067-475B-BEF7-5969FC9289E3Q37576874-1C04CA8F-E11B-427E-9908-F585040D55FFQ37671365-C30086D5-6979-4C0B-AE4E-4563B51F5B7AQ38131810-C3B1D9B2-EE5C-4B40-9336-18F951008183Q38151742-48ACEBD8-3F0C-4E41-AA5C-2F7A2E39D239Q38165233-F7B2834C-F286-4B4B-94DD-9BE9DFB08717Q38174084-2E522175-B9DC-4898-A16F-0A12CDA859B0Q38203613-E1E7ED49-F2CF-4AD4-ADB6-81DF1ADF6E7BQ38256777-5676DC1D-75CA-4AFB-84CA-B7A96DFB99F6Q38341856-939CE8BE-390E-4C0A-AE6F-7032720AF047Q38632265-903C0E04-7DDA-4085-8502-F9CC44976F66Q38658558-2CD80B6C-2337-4ECF-A348-86BD074B417AQ38787972-E1990305-6A21-4591-9FC7-7559FDFFB131Q38794071-2206E24F-837E-4477-9D11-5248BC8EB870Q38812765-049C41EB-4CC7-415E-BD0B-90C72017FBEAQ38930963-81938716-7C97-4238-885F-D0E36141F5F6Q38933737-FDFD01A8-413F-49F9-B019-9F8C95FCA729Q39119588-F83EAECC-ABF2-4D49-8B0B-259E3BDCF4E0Q39150394-6E8F4956-4A5A-4DF3-9D18-4E8A73725C52Q39174490-4131A313-6FFB-41DE-8205-642B62466799
P2860
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Towards global consensus on ou ...... esults of the HOME II meeting.
@en
type
label
Towards global consensus on ou ...... esults of the HOME II meeting.
@en
prefLabel
Towards global consensus on ou ...... esults of the HOME II meeting.
@en
P2093
P2860
P50
P1433
P1476
Towards global consensus on ou ...... esults of the HOME II meeting.
@en
P2093
Ake Svensson
Andreas Wollenberg
Arnold Oranje
Arnon Cohen
Carl-Fredrik Wahlgren
Carla Bruijnzeel-Koomen
Carolyn Charman
Carsten Flohr
Dedee F Murrell
Evelien Roekevisch
P2860
P304
P356
10.1111/J.1398-9995.2012.02874.X
P50
P577
2012-07-30T00:00:00Z